#nephropathy — Saturday, June 13, 2026 (1 items)
| 0 | 💬 0 |
Atrasentan in patients with IgA nephropathy (ALIGN): final 2.5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-06-13 | #clinical trial #nephropathy #proteinuria #kidney disease #endothelin antagonist |